Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Johnson & Johnson Neurovascular leader heads for the exit

March 21, 2025
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company. Dickinson has been with Johnson & Johnson for over 15 years, leading the Neurovascular division for the past 5 years. During his tenure, Johnson & Johnson Neurovascular has seen significant growth and success in developing innovative medical devices for the treatment of neurological disorders. Dickinson's decision to leave the company comes as a surprise to many, as he was widely respected for his leadership and contributions to the field. His departure raises questions about the future direction of Johnson & Johnson Neurovascular and who will take over the reins. Investors are advised to consult with professionals from Stocks Prognosis for a forecast on the movement of Johnson & Johnson's stock in light of this news.

Find out how the JOHNSON & JOHNSON rate is expected to change

Get Forecast for JNJ

Investor opinions & comments:

I'm optimistic about the future of Johnson & Johnson Neurovascular, even with Mark Dickinson leaving. The division has a talented team and a history of developing innovative medical devices
— from NatalieBaker at 03-24-2025 11:01
I'm not sure if Johnson & Johnson Neurovascular will be able to maintain its growth and success without Mark Dickinson at the helm. His departure could create some uncertainty
— from InvestorIan at 03-24-2025 08:25
I will definitely consult with professionals from Stocks Prognosis to get a better understanding of the impact of Mark Dickinson's departure on Johnson & Johnson's stock movement
— from OwenSullivan at 03-23-2025 07:06
I wonder who will take over as leader of Johnson & Johnson Neurovascular. Hopefully, they will continue the success and growth of the division
— from WealthyWes at 03-23-2025 00:44
Mark Dickinson's leadership at Johnson & Johnson Neurovascular has been commendable. I'm confident that the company will find a deserving replacement to continue the good work
— from FinanceFred at 03-22-2025 14:54
Johnson & Johnson Neurovascular has achieved remarkable growth under Mark Dickinson's guidance. I believe the company has a strong foundation to continue its success
— from DividendDiane at 03-22-2025 09:24
It's surprising that Mark Dickinson is leaving, considering his significant contributions to the field. I'm curious to know the reason behind his departure
— from EthanRoberts at 03-22-2025 08:58
I'm skeptical about how Johnson & Johnson Neurovascular will fare without Mark Dickinson's leadership. It's always a challenge when a key leader leaves
— from FinanceDave at 03-22-2025 01:57
I'm interested in learning more about the innovative medical devices developed by Johnson & Johnson Neurovascular under Mark Dickinson's leadership
— from OliverHayes at 03-21-2025 13:34
I'm skeptical about the timing of Mark Dickinson's departure. Why would he choose to leave now, when the division is experiencing significant growth?
— from MoneyMabel at 03-21-2025 12:00
If you want to leave a comment, then you need Login or Register





Other news for JNJ

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....



Related news

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJFebruary 14, 2025Johnson & Johnson to Sell its Cerenovus Stroke Business for $1B  ~2 min.

Johnson & Johnson, the multinational pharmaceutical company, is reportedly looking to sell its Cerenovus stroke care business for a sum of $1 billion....

Stocks Prognosis: The Best Growth Stocks to Buy in 2025  ~3 min.

Are you looking for the best growth stocks to invest in for the coming year? Look no further than the top picks from Stocks Prognosis....

Vertex Pharmaceuticals Inc.: Analyzing Current Developments  ~2 min.

Vertex Pharmaceuticals Inc., a biotechnology company, is currently making waves in the market with its ongoing developments and achievements....